Autologous Tissue Repair Becoming a Key Practice Area
Autologous Tissue Repair Becoming a Key Practice Area in Personalized Medicine
Greystone
Research Associates Identifies Process and Outcome
Improvements as Key Market Drivers
(Amherst, NH) – The ability to isolate,
purify and re-inject patient-derived cells with regenerative
properties has led to a number of therapeutic products for
the treatment of refractory injuries and wounds. Autologous
therapies are having an impact on a number of areas,
including cardiovascular medicine, refractory wound care,
orthopedics, and surgical medicine.
Applications for patient-derived tissue repair are expanding beyond traditional refractory wound care markets to encompass a growing list of surgical procedures and orthopedic restoration applications. The market for autologous tissue repair will continue to grow at an increasing rate due to favorable demographics. More than two-dozen autologous tissue repair products are currently being marketed or are in development, several with the potential to have a significant impact on regenerative medicine.
The potential economic benefits of autologous treatments are significant, as an aging population struggles with intractable ailments that historically have required numerous follow-up provider visits. While several approved autologous products require remote processing, the number of autologous therapeutics that can be processed at the point-of-care is increasing. Twenty-seven separate companies worldwide have products and development programs for autologous tissue repair – companies working to shape the future of tissue regeneration.
These findings are contained in a new and
comprehensive report: Autologous
Tissue Repair to 2018: Products, Indications, Markets and
Forecasts. The report contains in-depth analysis of
patient-derived therapies, clinical trial activities and
prospects for therapeutic indications that include
orthopedics, cardiovascular medicine, surgical procedures,
and wound care.
More information is available at
http://www.greystoneassociates.org
ENDS